B. Braun Lactated Ringer's Injection Recall for Particulate Matter
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
B. Braun Medical Inc. is recalling 23,688 bags of Lactated Ringer's Injection USP due to the presence of particulate matter.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on September 7, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, drug.
What Happened
B. Braun Medical Inc. initiated a voluntary recall of Lactated Ringer's Injection USP after discovering the presence of particulate matter.
Which Products Are Affected
The recall affects Lactated Ringer's Injection USP, 1000 mL EXCEL container (NDC 0264-7750-00), lot J4H077 with expiration date 30NOV2026. A total of 23,688 bags were distributed nationwide in the United States. The recall number is D-0832-2026.
What You Should Do
Consumers and healthcare facilities should immediately stop using the affected product and contact B. Braun Medical Inc. for return or refund instructions.
Why This Matters
This Class I recall involves an intravenous drug distributed across the U.S., posing a potential serious health risk due to particulate contamination.
Source
FDA recall D-0832-2026, B. Braun Medical Inc.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (842 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to September 7, 2026.
Frequently Asked Questions
Common questions about this FDA recall.